# Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics

> **NCT01019837** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Influenza H1N1

## Interventions

- **BIOLOGICAL:** Focetria (Monovalent MF59-Adjuvanted vaccine)

## Key facts

- **NCT ID:** NCT01019837
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-04
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01019837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01019837, "Efficacy and Safety of Vaccination Against Influenza H1N1 in Patients With Inflammatory Bowel Diseases (IBD) Treated Immunomodulators and Biologics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01019837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*